Citius Pharmaceuticals, Inc. (CTXR) › Operating Cash FlowCitius Pharmaceuticals, Inc. (CTXR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$20.8K2012: -$917.8K2013: -$1.10M2014: -$183.2K2015: -$2.39M2016: -$5.90M2017: -$7.97M2018: -$11.32M2019: -$12.44M2020: -$16.93M2021: -$24.25M2022: -$28.36M2023: -$29.06M2024: -$28.20M2025: -$26.55M-$26.55M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$26.55M+5.8%2024-$28.20M+3.0%2023-$29.06M-2.5%2022-$28.36M-17.0%2021-$24.25M-43.2%2020-$16.93M-36.1%2019-$12.44M-9.9%2018-$11.32M-42.0%2017-$7.97M-35.1%2016-$5.90M-147.4%2015-$2.39M-1202.3%2014-$183.2K+83.3%2013-$1.10M-19.3%2012-$917.8K-4316.5%2011-$20.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share